P2.13-35 Inhibition of H3K27 Demethylation Is Toxic in Poorly Differentiated Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1430
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Villin Expression Is Frequently Lost in Poorly Differentiated Colon Cancer

American Journal of Pathology
Forensic MedicinePathology
2012English

Overexpressed LAPTM4B-35 Is a Risk Factor for Cancer Recurrence and Poor Prognosis in Non-Small-Cell Lung Cancer

Oncotarget
Oncology
2016English

Dual Inhibition of EGFR and mTOR Pathways in Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

Is Immune Checkpoint Inhibition Part of Standard Therapy for Stage III Non-Small Cell Lung Cancer?

Cancer
Cancer ResearchOncology
2018English

P2.13-07 CUX1-ALK: A Novel ALK Rearrangement That Responds to Crizotinib in Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Increased Expression of the Immunosuppressive Interleukin-35 in Patients With Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

ERK Inhibition Represses Gefitinib Resistance in Non-Small Cell Lung Cancer Cells

Oncotarget
Oncology
2018English

Small-Cell Lung Cancer

Medical Herald of the South of Russia
2017English

Inhibition of SREBP Increases Gefitinib Sensitivity in Non-Small Cell Lung Cancer Cells

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy